GlassScriptPhysician profile
William B Cotton
NPI 1891802039
$7,643.53
in general payments reported to CMS, 2019-2025
36 companies · $782 in 2025
The $782 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,227 · 2022: $1,292 · 2023: $1,808 · 2024: $1,534 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,124.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $918.41 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $904.77 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $875.01 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $699.13 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $516.87 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $511.09 | 2021-2025 | Farxiga |
| Amgen INC. | $436.35 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $430.11 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $236.68 | 2021-2025 | |
| Novo Nordisk INC | $229.33 | 2021-2025 | Wegovy, Ozempic |
| Lexicon Pharmaceuticals, INC. | $225.53 | 2023-2024 | Inpefa |
| Preventric Diagnostics, INC. | $191.87 | 2021 | |
| Astellas Pharma US INC | $167.62 | 2021 | |
| Scpharmaceuticals INC. | $142.07 | 2023-2024 | |
| Medtronic, INC. | $132.32 | 2021-2025 | Corevalve Evolut R |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $131.78 | 2021-2023 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $119.95 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Alnylam Pharmaceuticals INC. | $109.15 | 2023-2025 | Amvuttra |
| Irhythm Technologies, INC. | $73.72 | 2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $68.32 | 2021-2023 | Nexletol |
| Kestra Medical Technology Services, INC. | $63.03 | 2024 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $62.30 | 2022-2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $59.93 | 2021-2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $56.34 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $45.83 | 2022-2023 | |
| Amarin Pharma, INC. | $41.10 | 2021 | |
| Edwards Lifesciences Corporation | $28.18 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Altathera Pharmaceuticals LLC | $21.98 | 2025 | Sotalol Hydrochloride |
| Endologix LLC | $21.44 | 2024 | Torus Stent Graft System, Endocross Device |
| Abbott Laboratories | $20.59 | 2021 | |
| Akcea Therapeutics, INC. | $20.21 | 2021 | |
| Philips North America LLC | $20.06 | 2023 | |
| Veryan Medical Incorporated | $18.72 | 2021 | |
| Chiesi USA, INC. | $18.18 | 2021 | |
| Angiodynamics, INC. | $16.56 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $9.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.